MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Antithrombotic Therapy After TAVI
Is aspirin enough?
By Antonio Greco, MD, and Davide Capodanno, MD, PhD
Structural Valve Deterioration and Bioprosthetic Valve Failure
Definitions, mechanisms, and treatment options.
By Paolo D’Arrigo, MD, and Davide Capodanno, MD, PhD
Radial Approach for Left Main and Bifurcation Stenting
Supporting data and technical aspects of an attractive route for complex coronary interventions.
By Davide Capodanno, MD, PhD
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI
Insight on the role of oral anticoagulation as default antithrombotic strategy after transcatheter aortic valve implantation.
Study Compares PCI to CABG in Left Main Coronary Artery Disease
September 20, 2011—In the Journal of the American College of Cardiology, Davide Capodanno, MD, et al published findings from a study that sought to determine the safety and efficacy of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with left main coronary artery (LMCA) disease (2011;58:1426–1432).
Early and Midterm Data From GHOST-EU Registry Published
July 18, 2014—EuroIntervention Editor-in-Chief Patrick Serruys, MD, announced the publication of the early and midterm outcomes of GHOST-EU, the largest (N = 1,189) European multicenter experience with the Abbott Vascular Absorb bioresorbable vascular scaffold (BVS) in real-world patients undergoing percutaneous coronary intervention (PCI).
Contemporary Issues in TAVR
By James McCabe, MD, and Darren Mylotte, MD
An Interview with Corrado Tamburino, MD
A European pioneer of left main intervention shares his perspective on important information for interventional cardiology practices worldwide.
Optimal Access/Reliable Closure
By Ted E. Feldman, MD, MSCAI, FACC, FESC
The Intricacies of TAVR
By Bernard Prendergast, DM, FRCP, FESC, and Isaac George, MD
Assessing Tricuspid and Mitral Interventions
By Rebecca T. Hahn, MD; Didier Tchétché, MD; and Dominick Angiolillo, MD
Two-Year SYNTAX Data Presented for Boston Scientific's Taxus Express for PCI
September 2, 2009—Boston Scientific Corporation (Natick, MA) announced 2-year data from its SYNTAX (Synergy Between Percutaneous Coronary Intervention [PCI] With Taxus and Cardiac Surgery) clinical trial comparing PCI using the company's Taxus Express paclitaxel-eluting coronary stent system to coronary artery bypass graft (CABG) surgery.
Mechanisms of Transcatheter Valve Degeneration
A translational perspective.
By Hacina Gill, BSc; David Meier, MD; Althea Lai, BSc; Geoffrey W. Payne, MSc, PhD; and Stephanie L. Sellers, MSc, PhD
Update on Transcatheter Mitral Valve Repair
A look at the current and soon-to-come transcatheter mitral valve repair options.
By Dale J. Murdoch, MBBS; Robert H. Boone, MD; Robert Moss, MBBS; John Webb, MD; and David A. Wood, MD
TAV-in-TAV: Future Considerations for Intermediate- and Low-Risk Patients
Challenges to the transcatheter management of severe aortic stenosis across a lifetime.
By Akshay Kamath, MD; Shravan Rao, MD; Brett Sheridan, MD; Christian Spies, MD; and David Daniels, MD
Catheter-Based Tricuspid Intervention
A review of current leaflet, annular, and valve replacement device technologies.
By Abdellaziz Dahou, MD, PhD; Juan F. Granada, MD; and Rebecca T. Hahn, MD
Considerations When Treating Patients With Multivalvular Heart Disease
Diagnosis and management of the most common subtypes of mixed and multivalvular heart disease.
By Juan del Cid Fratti, MD, and Christine J. Chung, MD
